Padcev 20 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FT5MN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,467
Award facts
- Contract value 100% obligated
- $20,467.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20.5K delivery order to Amerisourcebergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 20, 2026, for the supply of PADCEV 20 mg vials, with completion scheduled for February 10, 2026. This firm fixed-price, competitively awarded contract (no set-aside designation) will be performed at the contractor's Conshohocken, Pennsylvania facility. PADCEV (ado-trastuzumab vedotin) is a specialty oncology medication used in the treatment of certain cancers, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems.
This delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply an extensive range of pharmaceutical products, brand-name and generic medications, vaccines, and medical devices to support military healthcare programs worldwide. Amerisourcebergen's extensive federal contracting history and its established relationship with the Defense Logistics Agency position it as a critical vendor for federal medical procurement, serving military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT5MN?
SPE2DR26FT5MN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FT5MN worth?
The government has obligated $20,467 on SPE2DR26FT5MN.
Is contract SPE2DR26FT5MN an order under another contract?
Yes. SPE2DR26FT5MN is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5MN competed?
The extent of competition for SPE2DR26FT5MN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award